Platelet

There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.

A genetics-based platelet reactivity score can help identify people with a hyperreactive platelet phenotype who may have increased risk for a cardiovascular event, according to research published in Nature Communications.

A platelet reactivity score that identifies people with a hyperreactive platelet phenotype can be used to determine those who might be at elevated risk for a cardiovascular event, researchers reported in Nature Communications.

SAN DIEGO — Lower platelet count was identified as a significant predictor for ruxolitinib-induced moderate or severe thrombocytopenia in patients with myelofibrosis, according to research presented at ASH Annual Meeting and Exposition.

In this video, Aaron T. Gerds, MD, MS, discussed the backstory behind a study presented at ASCO Annual Meeting, examining the effect of the BET inhibitor pelabresib on patients with essential thrombocythemia.

The platelet-to-lymphocyte ratio has potential to be a marker of mortality for patients with AKI, according to data published in Kidney Medicine.

NEW ORLEANS — Efgartigimod demonstrated clinically significant improvement in platelet counts compared with placebo among adults with primary immune thrombocytopenia, results of the phase 3 ADVANCE IV trial showed.

Platelet inhibition strategies in people with MI undergoing PCI.

For this issue, Cardiology Today spoke with Editorial Board Member Jeffrey S. Berger, MD, associate professor of medicine and surgery with appointments in cardiology, hematology and vascular surgery at NYU Grossman School of Medicine and director of the Center for the Prevention of Cardiovascular Disease at NYU Langone Health.

Children with cancer face many obstacles that prevent them from having normal childhoods.